CUE BIOPHARMA INC. - COMMON STOCK
1,0900
25-ноября-24 09:14:32
15 мин. задержка
Акции
+0,0700
+6,86%
Сегодняшний диапазон
1,0500 - 1,1500
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
25 апр 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
21 мар 2023 15:10:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
15 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two March 2023 Investor Healthcare Conferences
01 мар 2023 07:00:02 Источник Nasdaq GlobeNewswire
-
22 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
16 фев 2023 09:30:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Announces the Appointment of Dr. Rafi Ahmed to its Scientific Advisory Board
16 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two February 2023 Scientific Conferences
01 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Announces Chief Medical Officer Transition
23 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
22 ноя 2022 07:00:04 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Reports Third Quarter 2022 Financial Results
14 ноя 2022 15:01:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
14 ноя 2022 07:20:14 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
09 ноя 2022 07:00:03 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
07 ноя 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
05 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
04 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two September 2022 Scientific Conferences
07 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
22 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Reports Second Quarter 2022 Financial Results
04 авг 2022 15:30:00 Источник Nasdaq GlobeNewswire